| Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation R Divella, R De Luca, I Abbate, E Naglieri, A Daniele Journal of Cancer 7 (15), 2346, 2016 | 347 | 2016 |
| Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer R Divella, A Mazzocca, A Daniele, C Sabbà, A Paradiso International journal of biological sciences 15 (3), 610, 2019 | 170 | 2019 |
| Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer A Daniele, AF Zito, G Giannelli, R Divella, M Asselti, A Mazzocca, ... Anticancer research 30 (9), 3521-3527, 2010 | 116 | 2010 |
| MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer M Quaranta, A Daniele, M Coviello, MT Venneri, I Abbate, ME Caringella, ... Anticancer research 27 (5B), 3593-3600, 2007 | 101 | 2007 |
| Epidermal growth factor receptor serum levels and prognostic value in malignant gliomas M Quaranta, R Divella, A Daniele, S Di Tardo, MT Venneri, I Lolli, ... Tumori Journal 93 (3), 275-280, 2007 | 71 | 2007 |
| Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (CXC motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients … R Divella, A Daniele, E Savino, F Palma, A Bellizzi, F Giotta, G Simone, ... Anticancer research 33 (4), 1491-1497, 2013 | 62 | 2013 |
| Co‐expression of CD133+/CD44+ in human colon cancer and liver metastasis A Bellizzi, S Sebastian, P Ceglia, M Centonze, R Divella, EF Manzillo, ... Journal of cellular physiology 228 (2), 408-415, 2013 | 61 | 2013 |
| Anticancer effects of nutraceuticals in the Mediterranean diet: an epigenetic diet model R Divella, A Daniele, E Savino, A Paradiso Cancer Genomics & Proteomics 17 (4), 335-350, 2020 | 60 | 2020 |
| Clinical and prognostic role of matrix metalloproteinase-2,-9 and their inhibitors in breast cancer and liver diseases: A review A Daniele, I Abbate, C Oakley, P Casamassima, E Savino, ... The international journal of biochemistry & cell biology 77, 91-101, 2016 | 60 | 2016 |
| Sorafenib: 10 years after the first pivotal trial G Gadaleta-Caldarola, S Infusino, R Divella, E Ferraro, A Mazzocca, ... Future Oncology 11 (13), 1863-1880, 2015 | 52 | 2015 |
| Assessment of nutritional and inflammatory status to determine the prevalence of malnutrition in patients undergoing surgery for colorectal carcinoma A Daniele, R Divella, I Abbate, A Casamassima, VM Garrisi, E Savino, ... Anticancer research 37 (3), 1281-1287, 2017 | 51 | 2017 |
| Sorafenib and locoregional deep electro‑hyperthermia in advanced hepatocellular carcinoma: A phase II study G Gadaleta‑Caldarola, S Infusino, I Galise, G Ranieri, G Vinciarelli, ... Oncology letters 8 (4), 1783-1787, 2014 | 50 | 2014 |
| Circulating levels of VEGF and CXCL1 are predictive of metastatic organotropismin in patients with colorectal cancer R Divella, A Daniele, R De Luca, M Simone, E Naglieri, E Savino, ... Anticancer research 37 (9), 4867-4871, 2017 | 49 | 2017 |
| The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer R Divella, A Daniele, I Abbate, A Bellizzi, E Savino, G Simone, ... Cancer Causes & Control 25, 1531-1541, 2014 | 42 | 2014 |
| Serotonin transporter polymorphism in major depressive disorder (MDD), psychiatric disorders, and in MDD in response to stressful life events: causes and treatment with … A Daniele, R Divella, A Paradiso, V Mattioli, F Romito, F Giotta, ... In vivo 25 (6), 895-901, 2011 | 41 | 2011 |
| Circulating levels of PAI-1 and SERPINE1 4G/4G polymorphism are predictive of poor prognosis in HCC patients undergoing TACE R Divella, A Daniele, I Abbate, E Savino, P Casamassima, G Sciortino, ... Translational oncology 8 (4), 273-278, 2015 | 37 | 2015 |
| Circulating transforming growth factor-β and epidermal growth factor receptor as related to virus infection in liver carcinogenesis R Divella, A Daniele, C Gadaleta, A Tufaro, MT Venneri, A Paradiso, ... Anticancer research 32 (1), 141-145, 2012 | 37 | 2012 |
| Circulating hTERT DNA in early breast cancer R Divella, S Tommasi, R Lacalamita, A Daniele, I Abbate, VM Garrisi, ... Anticancer research 29 (7), 2845-2849, 2009 | 36 | 2009 |
| Clinical and prognostic role of circulating MMP-2 and its inhibitor TIMP-2 in HCC patients prior to and after trans-hepatic arterial chemo-embolization A Daniele, R Divella, M Quaranta, V Mattioli, P Casamassima, A Paradiso, ... Clinical Biochemistry 47 (3), 184-190, 2014 | 35 | 2014 |
| Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond G Gadaleta-Caldarola, R Divella, A Mazzocca, S Infusino, E Ferraro, ... Future Oncology 11 (16), 2263-2266, 2015 | 28 | 2015 |
Ivan Lollioncologia medica, IRCCS Saverio De Bellis, Castellana Grotte在 irccsdebellis.it 的电子邮件经过验证
